Beta Blocker Recalled

Aurobindo Pharma USA Inc is recalling a single lot of metoprolol tartrate tablets after receiving reports that a metal wire was found in a tablet, according to the September 29, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 2820 bottles of 100-mg metoprolol tartrate tablets in 1000-count bottles (NDC 65862-064-99) from lot MJ1019025-A (Exp. 4/22). The tablets were distributed by Aurobindo Pharma USA, East Windsor, NJ, throughout the United States.

Aurobindo Pharma USA voluntarily initiated the recall September 9, 2021. The FDA designated the recall Class II on September 20, 2021. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.

Metoprolol is a prescription beta blocker used to treat high blood pressure and chest pain.